{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:45:33Z","timestamp":1792813533996,"version":"4.5.0"},"reference-count":32,"publisher":"Cambridge University Press (CUP)","issue":"16","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To identify the predictive and prognostic factors associated with ampicillin-resistant enterococcal bacteraemia, we retrospectively reviewed demographic, microbiological and clinical data of patients attending the Kyoto University Hospital, Japan, between 2009 and 2015. Logistic regression and Cox regression analyses were performed to determine the predictive and prognostic factors, respectively. In total, 235 episodes of enterococcal bacteraemia were identified. As ampicillin susceptibility was uniform for<jats:italic>Enterococcus faecalis<\/jats:italic>isolates and almost all ampicillin-resistant isolates were<jats:italic>E. faecium<\/jats:italic>, bacteraemia due to these species was investigated separately.<jats:italic>E. faecalis<\/jats:italic>and<jats:italic>E. faecium<\/jats:italic>accounted for 41.7% (98\/235) and 48.1% (113\/235) of the isolates, respectively and 91.2% of all<jats:italic>E. faecium<\/jats:italic>were ampicillin resistant. Nosocomial<jats:italic>E. faecium<\/jats:italic>bacteraemia acquisition (odds ratio (OR), 13.6; 95% confidence intervals, 3.16\u201358.3) was associated with ampicillin-resistant isolates. Bacteraemia from an unknown source (hazard ratio (HR), 2.91; 95% CI 1.36\u20136.21) and an increased Pitt bacteraemia score (PBS) (HR, 1.36; 95% CI 1.21\u20131.52) were associated with 30-day mortality in<jats:italic>E. faecium<\/jats:italic>infections. Likewise, bacteraemia from an unknown source (HR, 4.17; 95% CI 1.25\u201313.9) and increased PBS (HR, 1.27; 95% CI 1.09\u20131.48) were associated with 30-day mortality in patients with<jats:italic>E. faecalis<\/jats:italic>bacteraemia. The empirical therapeutic administration of glycopeptides is recommended for patients with bacteraemia from an unknown source in whom severe<jats:italic>E. faecium<\/jats:italic>bacteraemia is suspected.<\/jats:p>","DOI":"10.1017\/s0950268818002479","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T07:51:54Z","timestamp":1535701914000},"page":"2028-2035","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":11,"title":["Enterococcal bacteraemia: predictive and prognostic risk factors for ampicillin resistance"],"prefix":"10.1017","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2006-2298","authenticated-orcid":false,"given":"T.","family":"Matsumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ichiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"S0950268818002479_ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn390"},{"key":"S0950268818002479_ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12754"},{"key":"S0950268818002479_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2015.04.001"},{"key":"S0950268818002479_ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-1029-5"},{"key":"S0950268818002479_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12083"},{"key":"S0950268818002479_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.12.009"},{"key":"S0950268818002479_ref25","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"S0950268818002479_ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf216"},{"key":"S0950268818002479_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw383"},{"key":"S0950268818002479_ref20","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty-Second Informational Supplement. M100-S22; Vol. 32(3)."},{"key":"S0950268818002479_ref16","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12236"},{"key":"S0950268818002479_ref1","doi-asserted-by":"publisher","DOI":"10.1086\/421946"},{"key":"S0950268818002479_ref30","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/JCM.32.11.2671-2676.1994","article-title":"Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital","volume":"32","author":"McCarthy","year":"1994","journal-title":"Journal of Clinical Microbiology"},{"key":"S0950268818002479_ref29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.5.1032"},{"key":"S0950268818002479_ref9","doi-asserted-by":"publisher","DOI":"10.1086\/430909"},{"key":"S0950268818002479_ref7","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.2.296"},{"key":"S0950268818002479_ref8","doi-asserted-by":"publisher","DOI":"10.1086\/339211"},{"key":"S0950268818002479_ref12","unstructured":"Data from the ECDC Surveillance Atlas - Antimicrobial resistance. (https:\/\/ecdc.europa.eu\/en\/antimicrobial-resistance\/surveillance-and-disease-data\/data-ecdc). Accessed 28 March 2018."},{"key":"S0950268818002479_ref19","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2013.832482"},{"key":"S0950268818002479_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/0196-6553(88)90053-3"},{"key":"S0950268818002479_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.03.009"},{"key":"S0950268818002479_ref28","doi-asserted-by":"publisher","DOI":"10.2307\/30142363"},{"key":"S0950268818002479_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"S0950268818002479_ref2","doi-asserted-by":"publisher","DOI":"10.1086\/320185"},{"key":"S0950268818002479_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.02.012"},{"key":"S0950268818002479_ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013665"},{"key":"S0950268818002479_ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-009-0830-5"},{"key":"S0950268818002479_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu872"},{"key":"S0950268818002479_ref23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.12.2639"},{"key":"S0950268818002479_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.03.021"},{"key":"S0950268818002479_ref22","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-10-200211190-00007"},{"key":"S0950268818002479_ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074734"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268818002479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T15:45:09Z","timestamp":1604850309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268818002479\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":32,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0950268818002479"],"URL":"https:\/\/doi.org\/10.1017\/s0950268818002479","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2018\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}